Page 1 | Search Results | The Hematologist | American Society of Hematology

Skip Nav Destination

1-8 of 8

Sort by

Sort Order Select

Articles

Bending the Needle: Phase III MANGROVE Study in First-Line Mantle Cell Lymphoma

Tycel Phillips, MD

The Hematologist (2025) 22 (5)

https://doi.org/10.1182/hem.V22.5.2025512

Published: 2025

Articles

Hope for a New Standard of Care for Newly Diagnosed Diffuse Large B-Cell Lymphoma

Tycel Phillips, MD

The Hematologist (2025) 22 (4)

https://doi.org/10.1182/hem.V22.4.202542

Published: 2025

Articles

Does 1 + 1 = 2? Combining Targeted Agents in Frontline Chronic Lymphocytic Leukemia

Tycel Phillips, MD

The Hematologist (2025) 22 (3)

https://doi.org/10.1182/hem.V22.3.2025313

Published: 2025

Articles

Does This Star ‘GLO’? Taking Aim at Second-Line Diffuse Large B-Cell Lymphoma With Glofitamab Plus Gemcitabine and Oxaliplatin

Tycel Phillips, MD

The Hematologist (2025) 22 (2)

https://doi.org/10.1182/hem.V22.2.202526

Published: 2025

Articles

Game of Thrones: The New King in Advanced-Stage Hodgkin Lymphoma

Tycel Phillips, MD

The Hematologist (2025) 22 (1)

https://doi.org/10.1182/hem.V22.1.202529

Published: 2025

Articles

To Drive or Park the CAR: What Is the Best Option for Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma?

Tycel Phillips, MD

The Hematologist (2024) 21 (6)

https://doi.org/10.1182/hem.V21.6.2024613

Published: 2024

Articles

A Leap of Faith? Elimination of Autologous Stem Cell Transplantation for Patients With Mantle Cell Lymphoma in First Remission

Tycel Phillips, MD

The Hematologist (2024) 21 (5)

https://doi.org/10.1182/hem.V21.5.202455

Published: 2024

Articles

Generational Leap or Modest Step Forward? Non-Covalent Bruton Tyrosine Kinase Inhibition in Mantle Cell Lymphoma

Tycel Phillips, MD, Alex F. Herrera, MD

The Hematologist (2023) 20 (5)

https://doi.org/10.1182/hem.V20.5.202354

Published: 2023

Update search

NARROW

Publications

Format

Article Type

Date

Availability

Bending the Needle: Phase III MANGROVE Study in First-Line Mantle Cell Lymphoma

Hope for a New Standard of Care for Newly Diagnosed Diffuse Large B-Cell Lymphoma

Does 1 + 1 = 2? Combining Targeted Agents in Frontline Chronic Lymphocytic Leukemia

Does This Star ‘GLO’? Taking Aim at Second-Line Diffuse Large B-Cell Lymphoma With Glofitamab Plus Gemcitabine and Oxaliplatin

Game of Thrones: The New King in Advanced-Stage Hodgkin Lymphoma

To Drive or Park the CAR: What Is the Best Option for Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma?

A Leap of Faith? Elimination of Autologous Stem Cell Transplantation for Patients With Mantle Cell Lymphoma in First Remission

Generational Leap or Modest Step Forward? Non-Covalent Bruton Tyrosine Kinase Inhibition in Mantle Cell Lymphoma

Email alerts

ASH Publications

American Society of Hematology